《睡眠專業人士雜誌》
星期五, 七月 24, 2026
sovaSage™ announced the new release of Clinical Indicator Intelligence™, an enhanced feature within sovaGuide™ featuring Jeanie™. Using machine learning, the new capability continuously analyzes multiple PAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment. The […]
LivaNova PLC 宣布，美國食品藥物管理局（FDA）已核准 aura6000™ 系統用於治療中度至重度阻塞性睡眠呼吸中止症（OSA）的成人患者，並授予上市前核准（PMA）。 該系統採用近端舌下神經刺激（p-HGNS）——一種獨特的神經刺激療法——來治療患有 […] 的 OSA 患者。
ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for healthcare providers to treat sleep apnea and to help patients start and […]
CPAP Supply Statement “With the announcement of the suspension of shipping of PAP devices by Philips Respironics, 3B Medical has put together guidance for companies ordering CPAP. As always, 3B Medical will always give first priority to customers that have supported the company over the long term. Starting last week and concluding […]
“Bilevel Rescue” study presented at SLEEP 2018 conference A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP) therapy to a more advanced bilevel device in the first 90 days of treatment is an effective tool for achieving adherence in well more than […]
